Literature DB >> 29107391

The Application and Feasibility of Using Routine Data Sources for Long-term Cancer Clinical Trial Follow-up.

I S Bhattacharya1, J P Morden2, C Griffin2, C Snowdon2, R Brannan3, J M Bliss2, L Kilburn2.   

Abstract

Entities:  

Year:  2017        PMID： 29107391      PMCID： PMC6175051          DOI： 10.1016/j.clon.2017.10.007

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  5 in total

1.  Evidence-based public health: moving beyond randomized trials.

Authors:  Cesar G Victora; Jean-Pierre Habicht; Jennifer Bryce
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

2.  National Health Service Cancer Strategy for England: Where Are We Now?

Authors:  H S Kumar
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-03-10       Impact factor: 4.126

Review 3.  Innovative Solutions for Clinical Trial Follow-up: Adding Value from Nationally Held UK Data.

Authors:  S E Appleyard; D C Gilbert
Journal:  Clin Oncol (R Coll Radiol)       Date:  2017-10-26       Impact factor: 4.126

4.  Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.

Authors:  David Cameron; James P Morden; Peter Canney; Galina Velikova; Robert Coleman; John Bartlett; Rajiv Agrawal; Jane Banerji; Gianfilippo Bertelli; David Bloomfield; A Murray Brunt; Helena Earl; Paul Ellis; Claire Gaunt; Alexa Gillman; Nicholas Hearfield; Robert Laing; Nicholas Murray; Niki Couper; Robert C Stein; Mark Verrill; Andrew Wardley; Peter Barrett-Lee; Judith M Bliss
Journal:  Lancet Oncol       Date:  2017-06-07       Impact factor: 41.316

5.  It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence.

Authors:  C C Kirwan; C E Coles; J Bliss
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-06-22       Impact factor: 4.126
  5 in total
  1 in total

1.  Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial.

Authors:  Indrani S Bhattacharya; Joanne S Haviland; Penelope Hopwood; Charlotte E Coles; John R Yarnold; Judith M Bliss; Anna M Kirby
Journal:  Radiother Oncol       Date:  2019-02-28       Impact factor: 6.280
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.